Introduction
In mammalian DNA, the crucial function of cytosine methylation in chromatin structure and gene functions has led to the consideration of 5-methylcytosine (m5C) as the fifth base of DNA , . In addition to m5C, there are two other known methylated bases,
[1 2 ] N6-methyladenine (m6A) and N4-methylcytosine (m4C). However, m6A and m4C are generally considered to be specific to bacterial or protist DNA , and have not yet been identified in mammalian DNA. In prokaryotes, the function of m4C and m5C seems to be limited [3 ] to restriction-modification systems , although m5C is also part of the very short-patch repair system . On the contrary, the biological role of m6A in bacteria is more widespread, and includes postreplicative DNA mismatch repair, chromosome compaction and regulation of gene expression . Moreover, adenine methylation is essential for the virulence or viability of several pathogenic bacterial strains
[4 ] [6 -8 . This suggests that bacterial N6-DNA methyltransferase is a potential target for the design of new antimicrobial agents . The interest ] [9 ] for this new generation of antibiotics highlights the necessity for determining the existence of N6-DNA methyltransferases in higher eukaryotes.
The current assumption that m5C is the only methylated base present in animal DNA relies on experiments performed about thirty years ago with a detection limit of around 0.01 . However, even if analytical methods failed to detect m6A in mammalian DNA, % [10 -12 ] indirect evidence based on restriction enzyme analyses has suggested the presence of m6A in the mouse myogenic and the rat type 2 steroid 5 -reductase genes , . Hence, current analytical methods are sufficient to detect m5C in mammalian DNA (approximately 1
), but may be inadequate to detect the possible presence of a few hundred m6A in the 3.3 10 bases of the genome .
Homo sapiens [15 ] This suggests that the methylation status of adenine in mammalian DNA could be similar to the situation encountered a few years ago with cytosine methylation in . Indeed, it had been well-accepted that DNA from was not Drosophila melagonaster Drosophila melagonaster methylated, a belief recently challenged by the presence of m5C in this species . In this regard, the recent characterization of a [16 ] N6-adenine DNA methyltransferase from wheat coleoptiles suggests the occurrence of adenine methylation in higher eukaryotes . [17 ] A prerequisite for the presence of m6A in mammalian DNA is the expression of a N6-DNA methyltransferase. analyses of In silico mouse and human genomes have identified the existence of the PRED28 gene that encodes a putative N6-DNA methyltransferase ( ; GenBank gene ID: 29104). This gene is located on human chromosome 21 or http://harvester.embl.de/harvester/Q9Y5/Q9Y5N5.htm mouse chromosome 16, two chromosomes syntenic for this region. This situation prompted us to re-examine the methylation status of adenine in mammalian DNA.
Material and Methods
Bacterial strains TOP10 (Invitrogen) was used for transformation procedures and maintenance of plasmids.
GM 272 ( E. coli E. coli dam − , dcm − , ) was used for expression studies. This strain has mutations in genes encoding the adenine DNA methyltransferases and is hsdS − [18 ] therefore expected to have very little m6A in its DNA.
DNA purification and analysis

DNA analysis
Genomic DNA was extracted using the Genomic DNA buffer set and Qiagen Genomic Tip from Qiagen (Qiagen, Courtaboeuf, France). Human placental mitochondria were purified as described . Mitochondrial DNA was extracted using the QIAamp DNA kit [19 ] from Qiagen (Qiagen, Courtaboeuf, France). Subsequently, genomic or mitochondrial DNA was incubated with a mixture of endo-and exonucleases, and alkaline phosphatase that quantitatively liberate N6-methyldeoxyadenosine (MedAdo) . This was demonstrated [20 ] using plasmid DNA that contained a known amount of MedAdo. A HPLC electrospray ionization tandem mass spectrometry (HPLC [23 ] S N = 3) for the assay were close to 20 fmol of injected MedAdo (corresponding to a concentration of 0.5 nM). Quantification was performed by external calibration, and the amount of DNA was determined by UV absorption using the peak of deoxyguanosine . 
Cloning of PRED28 splice variants
The coding regions of PRED28 and PRED28 were amplified by RT-PCR from embryonic mouse brain mRNA and cloned into (Invitrogen). For selection of stable recombinant clones, zeocin (100 g/ml) was added 72 hr after transfection. Expression was verified by μ immunofluorescence staining and western blot using a V5 antibody (Invitrogen).
Bacterial expression of recombinant PRED28
For the bacterial expression of recombinant proteins, GM272 clones harboring either pBAD/PRED28 or pBAD/PRED28 E. coli concentration) was added to one of the cultures to induce protein production. After one hour, the bacteria were centrifuged and processed for either DNA extraction or for western blot analysis. For western blot analysis, cell pellets were resuspended and lysed in CelLytic ™ buffer (Sigma). Then, cell lysates were centrifugated at 18 000 g for 15 minutes to pellet the insoluble material. Western blot analyses × were performed on both the supernatant and insoluble fractions using a V5 antibody (Invitrogen). For DNA analysis, DNA was extracted using the DNA genomic buffer set from Qiagen according to the manufacturer s instructions.
'
Results
Determination of m6A content in mammalian and mitochondrial DNA Previous base analyses of mammalian DNA have failed to detect the presence of m6A. However, these analyses were performed over twenty years ago with a detection threshold around 0.01 . Therefore, in an attempt to re-examine the problem of adenine methylation in % mammalian DNA, we have developed an extremely sensitive assay for MedAdo with a detection threshold of one MedAdo per 10 6
nucleosides. However, even using this sensitive assay we were unable to detect adenine methylation in the nuclear DNA of several mouse tissues ( ). According to the size of the mouse genome (2.5 Gb), these results suggest that the total mouse genome contains less Table 1 than 2.5 10 m6A. In addition, since it has been suggested that mitochondria could be the degenerate descendants of endosymbiotic × 3 bacteria, and since bacterial DNA is known to contain m6A, mitochondrial DNA from human placenta was also included in this study. In contrast to bacterial DNA, which contains MedAdo, no MedAdo was detected in mitochondrial DNA ( ). Table 1 Tissue expression profile of PRED28/N6AM1, a putative N6-DNA methyltransferase
The presence of less than 10 m6A in the whole mouse genome could be biologically significant if adenine methylation occurs in rare 3 specific gene regulatory elements. However, it is difficult to demonstrate the existence of a base which is below the detection limits of current analytical methods. This difficulty can be circumvented if we consider that a prerequisite for the presence of m6A is the existence of a gene coding for a N6-DNA methyltransferase. Analysis of the human and mouse genomes reveals the presence of PRED28/N6AM1 on human chromosome 21, or on mouse chromosome 16, which was annotated as a putative N6-DNA methyltransferase on the basis of in analysis (GenBank accession AY456393). In order to determine the tissue expression profile of PRED28, oligonucleotide primers silico for the mouse PRED28 cDNA sequence deposited in GenBank (accession AY456393) were used to amplify PRED28 mRNA. RT-PCR analysis of mRNA derived from several mouse tissues demonstrates that the PRED28 gene is expressed in all the tissues examined (Fig. 1 ). Interestingly, two PRED28 isoforms, named PRED and PRED , were detected in mouse tissues. The longer PRED28 isoform 
Cloning and Characterization of PRED28 isoforms
To characterize these two mRNAs, molecular cloning and DNA sequencing of the corresponding PRED28 and PRED28 cDNA α β were performed. Nucleotide sequences confirm that the PRED28 sequence corresponded to the sequence of the N6-DNA α Mus musculus methyltransferase mRNA already deposited in GenBank under accession AY456393, which encodes for a 23 kDa putative protein (214 amino acids). In contrast, the PRED28 sequence corresponded to a new transcript variant that we deposited under accession AY536887.
β Interestingly, this alternative splicing introduces a frame shift that generates a stop codon soon after the beginning of exon VI. Thus, PRED cDNA encodes a putative protein of 14.7 kDa (138 amino acids) ( ). 
Subcellular Localization of PRED28 isoforms
To gain insight into the biological function of the PRED28 protein, we analyzed the subcellular localization of the two PRED28
isoforms. For this purpose, full-length coding sequences corresponding to PRED28 and PRED28 were cloned into the eukaryotic 
PRED28 expression in E. coli and C2C12 cells
To investigate the ability of PRED28 to methylate adenine residues in DNA, PRED28 and PRED28 were expressed in the α β E. coli GM272 strain. GM272 is a , mutant . Thus, GM272 DNA contains low levels of m6A and is therefore a useful hsdr − , dam − dcm − [18 ] tool to determine if PRED28 production can induce methylation of DNA. DNA fragments encoding either PRED28 or PRED28 were ). Therefore, we conclude that under our assays conditions, PRED28 has no detectable adenine α β 
Discussion
In order to re-investigate the adenine methylation status of mammalian DNA, we developed an extremely sensitive assay for MedAdo detection. Using this assay, which is over 100 times more sensitive than previous methods, we were unable to identify adenine methylation in the nuclear DNA of several mouse tissues or in human mitochondrial DNA. Hence, if adenine methylation occurs, it would only comprise a few hundred adenines. Alternatively, adenine methylation could be restricted to a minor population of cells (i.e. stem cells), or may occur during a brief period of the cell cycle. Moreover, it should be noted that the presence of a few m6A in DNA may be critical if they are used to control the expression of a small subset of transcription factors or miRNAs. In this regard, it is noteworthy that the artificial methylation of adenine in several eukaryotic or viral promoters alters their activity . Moreover, the addition of MedAdo [24 -27 ] to cell culture medium has been reported to induce cell differentiation , . [23 28 ] An alternative way to determine the presence of m6A in mammalian genomes is to investigate the existence of a N6-DNA methyltransferase in mammalian cells. On the basis of bioinformatic analysis, a gene named PRED28, already annotated as coding for a putative N6-DNA methyltransferase, has been found in murine and human genomes. In humans, two mRNA species resulting from the alternative splicing of exon IV have been described (NM_013240 and NM_182749) ( ). Removal of exon IV would be critical for the Fig. 2 enzymatic activity of the protein since it codes for the NPPY motif characteristic of N6-DNA methyltransferases ( ). This would [29 ] Fig. 2 suggest that the shorter human variant, named PRED , should be devoid of enzymatic activity. Our results show that in mice, PRED is nuclear entry of the PRED proteins could be caused by passive diffusion through the NPC. Interactions of these two PRED isoforms with nuclear proteins or nucleic acids could limit their export from the nucleus. This could explain their preferential localization in the nucleus
Even though a N6-DNA methyltransferase is predicted to display nuclear localisation, expression of PRED28 isoforms in bacteria or in mammalian cells failed to demonstrate any adenine DNA methyltransferase activity. A possible explanation for the lack of N6-DNA methyltransferase activities of PRED proteins in our methylation assays could be the absence of unidentified cofactor(s) required for enzymatic activity. Likewise, the tag used to identify the recombinant PRED proteins may interfere with proper activity. Alternatively, the annotation of PRED28 as a putative N6-DNA methyltransferase could have been erroneous. Indeed, the NPPY motif characteristic of N6-DNA methyltransferases was recently found to be shared by HemK proteins. The HemK protein was initially misidentified and annotated as a component of the heme biosynthetic pathway . However, it is now recognized as a bacterial N5-glutamine [31 ] methyltransferase . Therefore, the possibility that PRED28 is an uncharacterized mammalian N5-glutamine methyltransferase should [32 ] be considered. This point warrants further investigation because the human PRED28 gene is localized on chromosome 21, and it may have a possible contribution to the pathology of Down syndrome.
On the basis of computer analysis, open reading frames distinct from PRED28 which code for several other putative N6-DNA methyltransferases have been detected in eukaryotic genomes . This raises the possibility that in higher eukaryotes, proteins other than [33 ] PRED28 could be involved in the methylation of a small number of adenine residues, a point of crucial concern if N6-DNA methyltransferase inhibitors are to be used as antibiotics , . RT-PCR analysis of the tissue specific (A) and developmental expression (B) of PRED28 in mouse Although both PRED and are ubiquitous in all tissues examined, PRED is expressed at higher levels than PRED in adult tissues. α β α β
Fig. 2
Genomic organization and structure of alternatively spliced transcripts of mouse and human PRED28 The splicing of exon V in the mouse PRED28 results in a frame shift. The two resulting alternative amino-acid sequences encoded by the mouse exon VI are shown. GeneBank accession numbers are included. anti-V5 antibody (Invitrogen) and DNA is labelled in red by propidium iodide. 
